BioSpace takes a look at Moderna at the similarities between the two, and a few differencesPfizer-BioNTech and Moderna Covid-19 vaccines preliminary data readout of its COVID-19 vaccine suggested a 90% efficacy rate, the U.S. and western countries have the promise of two effective and reasonably safe vaccines. There are . Here’s a look.
New Jersey and Philadelphia announce new restrictions as Covid-19 surges across United States
California, Coronavirus Disease 2019 (COVID-19), Coronavirus Restrictions, Dr. Anthony Fauci (Director), Gavin Newsom (Calif.), Hospitalized COVID-19 Patients, Indoor gathering bans, Michelle Lujan Grisham (New Mexico), Michigan, MSNBC, New Jersey, Phil Murphy (NJ), Philadelphia, Reuters Tally, WisconsinThe city of Philadelphia will ban indoor gatherings altogether and the nearby state of New Jersey will strictly limit their size as U.S. officials struggle to slow a Covid-19 surge that could overwhelm hospitals and kill thousands.
Fauci not advising Biden, sees no reason to quit Trump now: Reuters interview
Coronavirus Disease (COVID-19) Pandemic, Donald Trump, Dr. Anthony Fauci (Director), Joe Biden, Masks, National Institute of Allergy and Infectious Diseases (NIAID), Reuters, Social Distancing, White House coronavirus task forceDr. Anthony Fauci, the top U.S. infectious disease expert, said he has had no contact with President-elect Joe Biden’s coronavirus transition team and sees no reason to quit to join that effort when there is so much to do now to fight the surging pandemic.
Moderna On Track for Early Data Readout for Covid-19 Vaccine in November
BioNTech, Business, Clinical Trials, Covid-19 Data, COVID-19 Vaccines, Dr. Anthony Fauci (Director), Emergency Use Authorization, FDA, Interim Analysis, Messenger RNA (mRNA) Vaccines, Moderna, National Institute of Allergy and Infectious Diseases (NIAID), Pfizer, R&DModerna is projected to have data to report by the end of November on the company’s Covid-19 vaccine program.
U.S. allows emergency use of first Covid-19 antibody drug
Adults 65 and Older, Business, Clinical Trials, COVID-19 antibody drugs, Dr. Anthony Fauci (Director), Emergency Use Authorization, FDA, Hospitalized COVID-19 Patients, Monoclonal Antibodies, R&D, Regeneron Pharmaceuticals, Shares, White HouseU.S. regulators authorized emergency use of the first experimental antibody drug for Covid-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions.
Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, greeted news about the vaccine against the deadly coronavirus that Pfizer Inc. is developing as “a big deal” and said the United States could have vaccine doses ready to administer to people before the end of 2020.
ViiV’s Cabotegravir Beats Out Gilead’s Truvada for Preventing HIV in Women
Blockbusters, Clinical Data, Clinical Trials, HIV Prevention, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Mental Health, R&D, Shareholders, The Bill and Melinda Gates Foundation, Therapeutics, WomenViiV Healthcare announced that an independent data safety monitoring board (DSMB) recommended the early unblinding of data from the HIV Prevention Trials Network 084 trial of the investigational, long-acting injectable cabotegravir for HIV prevention in women.
Task force sees ‘unrelenting’ Covid-19 spread; daily U.S. cases up by record 91,000
Arizona, CNN, Donald Trump, Dr. Anthony Fauci (Director), Elections, Hospitalized COVID-19 Patients, Joe Biden, Midwest, Mike DeWine (Ohio), National Institute of Allergy and Infectious Diseases (NIAID), Temperature, Utah, West, White House coronavirus task forceThe White House coronavirus task force warned that much of the country is in the grips of an “unrelenting” surge in Covid-19 cases and urged tough countermeasures, as the reported number of U.S. infections hit a new daily record of more than 91,000.
U.S. infectious disease expert Anthony Fauci said it would be clear whether a Covid-19 vaccine was safe and effective by early December, but that more widespread vaccination would not be likely until later in 2021.
President Donald Trump, under fire over his handling of the coronavirus epidemic, announced that the federal government would ship 150 million rapid tests to U.S. states and warned an increase in positive cases is likely in the days ahead.